USMedicine.com posts on Lejeune & Civilian Exposure

Recently, US Medicine reached out to us regarding the latest developments with Camp Lejeune contamination.  In the article, we were asked about the meaning of a move by the VA to work towards establishing presumptive status for veterans exposed.  Of course, this is a great outcome and much needed for veterans.  Thankfully, one segment of those affected by Camp Lejeune contamination are starting to see progress.  But we reminded those at US Medicine that there is another contingent that still faces little to no recourse whatsoever for the health impacts of the negligence at Lejeune – civilian employees and non-active duty citizens present on the base as support personnel.

There needs to be a comprehensive, standardized solution for ALL people at ALL bases facing contamination issues across this country.  Lejeune is the flagship, but it is one of over 150 installations with problems currently present on the EPA Superfund site list.

**Read more from the US Medicine article on Lejeune and Civilian Exposure.

In addition, another article published this month highlights some of the recent studies that have come to light from the CDC.  You can find these same studies and our assessment by clicking this link – Civilian Exposure – 2014-2015 CDC Lejeune Studies Summary and Assessment. The complete article highlights a recently updated male breast cancer study, as well as a 2014 Civilian Mortality Study.

“Some occupational studies have found TCE associated with rectal cancer and prostate cancer, and these were also elevated among Marines/Navy personnel and civilian workers at Camp Lejeune, compared to Camp Pendleton.”

**Have a look at their findings in this additional US Medicine article on Lejeune studies.

The post USMedicine.com posts on Lejeune & Civilian Exposure appeared first on Civilian Exposure.